HIBSAGO Trademark
Trademark Overview
On Thursday, August 11, 2022, a trademark application was filed for HIBSAGO with the United States Patent and Trademark Office. The USPTO has given the HIBSAGO trademark a serial number of 97545155. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Monday, May 26, 2025. This trademark is owned by Glaxo Group Limited. The HIBSAGO trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
General Information
| Serial Number | 97545155 |
| Word Mark | HIBSAGO |
| Filing Date | Thursday, August 11, 2022 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Monday, May 26, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 12, 2024 |
Trademark Statements
| Goods and Services | Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 31, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Glaxo Group Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY
GB |
| Party Name | Glaxo Group Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY
GB |
Trademark Events
| Event Date | Event Description |
| Wednesday, May 31, 2023 | SUSPENSION LETTER WRITTEN |
| Monday, August 15, 2022 | NEW APPLICATION ENTERED |
| Wednesday, August 31, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 30, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, May 31, 2023 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, May 31, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, July 12, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, July 12, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, July 12, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, January 10, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Wednesday, September 27, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, February 7, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 12, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 12, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 7, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 5, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 5, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 7, 2024 | NOTICE OF ALLOWANCE CANCELLED |
| Monday, May 26, 2025 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
